- According to experts, successful listing of Tarson products in the secondary markets is possible.
- Life science company Tarson Products had an IPO of 77.49 times
- According to unofficial market active traders, the shares of Tarson Products are trading at a premium of Rs 175-180.
According to unofficial market active traders, Tarson Products shares are trading at a premium of Rs 175-180. Which is 27 percent more than the company’s IPO price band. Investors are also confused about whether their shares should be retained or sold if Tarson’s products make a listing profit.
Ayush Agarwal, Senior Research Analyst, Swastik Investmart, Merchant Banking said, “Financially, Tarson has strong products and impressive margins. Its management is also very experienced. The company has strong cash flows and is likely to come out of debt post the IPO. However, its valuations seem to be slightly higher, so aggressive investors may hold on to it in the long run. Whereas those who want to make profit in listing should book profit.
“Based on gray market trends and subscription data, I expect listings to grow by 20-25 per cent,” he said. Life science company Tarson Products had an IPO of 77.49 times. According to NSE data, bids were received for 84,02,81,684 shares against 1,08,44,104 shares. The issue is worth Rs 150 crore and has a price band of Rs 635-662 per share.
Tarson Makes Labware Products
Tarson Products designs, develops and manufactures laboratory equipment products used in research organizations, educational institutions, pharmaceuticals companies, diagnostics companies and hospital laboratories. Its Labware products are of excellent quality and help to improve healthcare.
Anchor investors of Tarson Products include Monetary Authority of Singapore, Government of Singapore, Abu Dhabi Investment Authority, ICICI Prudential Mutual Fund (MF), Sundaram MF, Aditya Birla MN, Adil Birla Sun Lions.
Disclaimer: The above information is for information only. Its purpose is not to advise you to buy or sell any shares. Be sure to consult your financial advisor before making any investment.